NOVEL CTLA4-IG IMMUNOADHESINS

The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.

Saved in:
Bibliographic Details
Main Authors LAZAR, Gregory, BERNETT, Matthew
Format Patent
LanguageEnglish
Lithuanian
Published 10.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.
Bibliography:Application Number: LT15198516T